small cell lung cancer
OncoHost, Hengenix Biotech Exploring Lung Cancer Resistance Biomarkers in Immunotherapy Trial
Researchers will search for biomarkers linked to resistance in small cell lung cancer patients receiving serplulimab with chemotherapy in a Phase III trial.
Puma Biotech IND Cleared to Begin Alisertib Monotherapy Trial in Small Cell Lung Cancer
The Los Angeles-based firm will explore alisertib's efficacy in specific biomarker subgroups in the 60-patient Phase II trial.
Although traditional biomarker-targeted therapies haven't benefitted patients with this aggressive form of lung cancer, pharma firms and researchers are trying out new biomarkers and ctDNA monitoring.
Y-mAbs Launches Phase I Trial of GD2-Targeted Radioimmunotherapy
The company will determine an optimal dose and evaluate safety and initial efficacy in a three-part trial involving 60 patients.
Tempus, AstraZeneca Collaborate on Response Biomarker Discovery for Small Cell Lung Cancer
This clinical study, called Sculptor, is the first research to emerge from a strategic collaboration between the companies on oncology therapeutics.